|Articles|January 2, 2004
- Pharmaceutical Technology-01-02-2004
- Volume 28
- Issue 1
Medicare Bill Contains Significant Changes for Drug Manufacturers
Author(s)Jill Wechsler
The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.
Advertisement
Articles in this issue
about 22 years ago
Coprocessed Excipients for Solid Dosage Formsabout 22 years ago
Manufacturing Execution Systemsabout 22 years ago
State-of-the-Art Packaging Machinesabout 22 years ago
January 2004about 22 years ago
The Bioterrorism Actabout 22 years ago
New Supply-Chain Dynamicsabout 22 years ago
In the Spotlight--February 2004about 22 years ago
January 2004Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
4
Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining
5